Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · MAXCYTE, INC. (MXCT)

MaxCyte regains Nasdaq minimum bid price compliance; matter now closed

Positive Impact 3 of 5 legal/regulatory Written later

MaxCyte received a Nasdaq letter on June 10, 2026 stating that its common stock closed at $1.00 or above for the last 10 consecutive business days, from May 27 to June 9, 2026. Nasdaq closed the matter, and the company says it has regained compliance with the minimum bid price rule. This removes the bid price deficiency that Nasdaq had flagged in March 2026.

Key points

  • Nasdaq notice on March 16, 2026 cited a closing bid price below $1.00 for 30 consecutive trading days
  • Nasdaq letter dated June 10, 2026 confirmed the closing bid price was at $1.00 or greater from May 27 to June 9, 2026
  • Nasdaq closed the matter under Listing Rule 5450(a)(1)

The filing

CompanyMAXCYTE, INC. (MXCT)
Form8-K, current report
Filed with the SECJun 16, 2026, 4:21 PM ET
Accession number0001104659-26-074594

Items reported: 3.01 Delisting / Listing Rule Notice

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:36 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on June 16, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.